Phase I-II Study in CD30 Positive Diffuse Large B-cell Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse
Clinical trial NCT03356054 · RECRUITING
Trial details
- NCT number
- NCT03356054
- Sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2023-01-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.